Qinqin Zha

Qinqin Zha currently serves as Principal Scientist and Associate Director at NeoGenomics Laboratories, where responsibilities include leading NGS assay development and launching a new comprehensive genomic profiling product. Prior experience includes roles as Senior Scientist at NeoGenomics, where Qinqin oversaw planning and execution for molecular offerings, and as Research Scientist III at ResearchDx, focusing on NextGen Sequence technology and clinical diagnostic assay validation. Qinqin also held positions at MEDomics as Director of the diagnostic team and Senior Expert Mutation Analyst, and at Baxter Healthcare as Research Associate III. Academic qualifications include a Ph.D. in Biochemistry, Molecular Biology, and Psychiatry from Peking University Health Science Center, along with a Doctor of Medicine from Nanchang University and a Certificate in Data Analytics and Visualization from the University of California, Irvine.